LAUREN FRANKOFF: Open Payments
NPI 1912414509 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,771 in 51 payments from 14 companies in 2025. Trend: 2023 $2,124 · 2024 $3,012 · 2025 $2,771
Food & beverage: $1,842Travel & lodging: $929
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 26 | $1,767 |
| Amgen Inc. | 11 | $342 |
| Impulse Dynamics (USA) Inc. | 1 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $138 |
| Edwards Lifesciences Corporation | 2 | $64 |
| ABIOMED | 1 | $55 |
| CVRx, Inc. | 1 | $55 |
| Novartis Pharmaceuticals Corporation | 1 | $38 |
| Medtronic, Inc. | 1 | $30 |
| Boston Scientific Corporation | 1 | $29 |
Products named: CARDIOMEMS, REPATHA, Optimizer, Kerendia, Barostim Neo System, PASCAL, LEQVIO, COREVALVE EVOLUT R.
Industry payments across TX — which companies pay providers there.
